Metabolic and Bariatric Surgery · 1 July 2024

Post-Bariatric Surgery Statin Discontinuation and ASCVD Risk

Post-bariatric surgery statin discontinuation poses significant risks for ASCVD events, particularly in patients with prior ASCVD and certain demographics like Hispanics. Primary prevention patients have an 82% reduced risk of post-statin cessation ASCVD events compared to secondary prevention patients. Individualized healthcare strategies are needed, especially for those over age 40 with diabetes. Comprehensive cardiovascular evaluations are crucial for making optimal decisions regarding statin cessation.

Journal Article by Alsuhibani AA, Al-Kadi A (…) Hincapie AL et 4 al. in BMC Surg

read the whole article in BMC Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

Ann Surg13 Jul 2026

Predictive Models Enhance Diabetes Remission After Surgery

A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.

Ann Surg16 Jun 2026

EndoBarrier Shows Promise for Type 2 Diabetes in Obesity

Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.

All papers in Metabolic and Bariatric Surgery →